Cargando…
S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS
BACKGROUND: This study reports on clinical data from an 8-week open-label study of 20 HIV-seropositive individuals, diagnosed with Major Depressive Disorder (DSM-IV), who were treated with SAM-e (S-Adenosylmethionine). SAM-e may be a treatment alternative for the management of depression in a popula...
Autores principales: | Shippy, R Andrew, Mendez, Douglas, Jones, Kristina, Cergnul, Irene, Karpiak, Stephen E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535560/ https://www.ncbi.nlm.nih.gov/pubmed/15538952 http://dx.doi.org/10.1186/1471-244X-4-38 |
Ejemplares similares
-
Paramagnetic Intermediates Generated by Radical S-Adenosylmethionine
(SAM) Enzymes
por: Stich, Troy A., et al.
Publicado: (2014) -
S-Adenosylmethionine (SAM)-Dependent
Methyltransferase MftM is Responsible for Methylation of the Redox
Cofactor Mycofactocin
por: Ellerhorst, Mark, et al.
Publicado: (2022) -
Low sulfide levels and a high degree of cystathionine β-synthase (CBS) activation by S-adenosylmethionine (SAM) in the long-lived naked mole-rat
por: Dziegelewska, Maja, et al.
Publicado: (2016) -
Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications
por: Mahmood, Niaz, et al.
Publicado: (2017) -
Understanding the experience and manifestation of depression in people living with HIV/AIDS in South Africa
por: Andersen, L., et al.
Publicado: (2015)